Treatment of Urinary Tract Infections in Men

All UTIs in men are classified as complicated infections requiring 14 days of antibiotic therapy when prostatitis cannot be excluded, which applies to most presentations. 1, 2

First-Line Antibiotic Selection

Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 14 days is the preferred first-line agent for male UTIs. 2, 3, 4

Alternative First-Line Options:

Ciprofloxacin 500-750 mg twice daily for 14 days - Use ONLY when local fluoroquinolone resistance is <10%, the patient has not used fluoroquinolones in the past 6 months, and the patient is not from a urology department 1, 2
Levofloxacin 750 mg once daily for 14 days - Same restrictions as ciprofloxacin apply 1, 2

Second-Line Oral Options:

Cefpodoxime 200 mg twice daily for 14 days 1, 3
Ceftibuten 400 mg once daily for 14 days 1, 3

Critical Evidence on Treatment Duration

A 2017 randomized trial demonstrated that 7-day ciprofloxacin was significantly inferior to 14-day treatment in men (86% vs 98% cure rate, p=0.025). 2, 3 This high-quality evidence definitively establishes that shorter courses are inadequate for male UTIs.

A shorter duration of 7 days may only be considered if the patient becomes afebrile within 48 hours and shows clear clinical improvement, though this remains controversial given the above evidence. 1, 2

Mandatory Diagnostic Steps

Before Initiating Antibiotics:

Obtain urine culture and susceptibility testing - This is mandatory to guide therapy adjustments if empiric treatment fails 1, 2
Perform digital rectal examination - To evaluate for prostate involvement, as unrecognized prostatitis requires the full 14-day course 3

Evaluate for Underlying Urological Abnormalities:

History of voiding difficulties or incomplete bladder emptying 1
Acute urinary retention at presentation 5
Presence of microscopic hematuria at follow-up 5
Early recurrent symptomatic UTI 5

Microbiology and Resistance Patterns

The microbial spectrum in male UTIs is broader than uncomplicated UTIs, with increased likelihood of antimicrobial resistance. 1, 2 Common pathogens include:

E. coli (most common) 1, 4
Proteus species 1, 4
Klebsiella species 1, 4
Pseudomonas species 1
Enterococcus species 1

Special Populations

Men with Diabetes:

Treat identically to non-diabetic men with 14 days of therapy. 2 Diabetes is a complicating factor that increases UTI severity and risk of resistant pathogens, but does not change the antibiotic selection algorithm. 6, 7 There is no indication to treat asymptomatic bacteriuria in diabetic men. 7

Men with Immunosuppression:

These patients have complicated UTIs with higher risk of multidrug-resistant organisms. 1 Consider broader-spectrum empiric therapy with:

Piperacillin-tazobactam 2.5-4.5 g three times daily 2
Ceftriaxone 1-2 g once daily 2

De-escalate to narrower-spectrum agents once culture results return. 2

Agents to AVOID

Do NOT Use as First-Line:

Amoxicillin or ampicillin - High worldwide resistance rates make these inappropriate for empiric therapy 2
Cephalexin - Poor urinary concentration and limited efficacy against common uropathogens 3
Amoxicillin-clavulanate (Augmentin) - Not recommended as first-line; reserve for culture-directed therapy only when susceptibility is confirmed 3

Fluoroquinolone Restrictions:

Avoid fluoroquinolones when: 2, 3

Patient is from a urology department
Patient has used fluoroquinolones in the last 6 months
Local resistance rates exceed 10%
Other effective options are available (due to FDA warnings about disabling adverse effects)

Common Pitfalls to Avoid

Failing to obtain pre-treatment urine culture - This complicates management if empiric therapy fails 2, 3
Using inadequate treatment duration - 7-day courses lead to treatment failure in men, particularly when prostate involvement is present 2, 3
Treating asymptomatic bacteriuria - This increases risk of symptomatic infection and bacterial resistance without benefit 3, 8
Ignoring the possibility of prostatitis - When prostatitis cannot be excluded (most cases), the full 14-day course is mandatory 1, 2
Not evaluating for urological abnormalities - Focus on lower urinary tract pathology (obstruction, incomplete voiding, retention) rather than routine upper tract imaging 5

Parenteral Therapy for Severe Presentations

When Patient Requires Hospitalization:

Ceftriaxone 1-2 g IV once daily 2
Piperacillin-tazobactam 2.5-4.5 g IV three times daily 2
Amoxicillin plus aminoglycoside 2
Second-generation cephalosporin plus aminoglycoside 2

Transition to oral therapy once the patient is hemodynamically stable and afebrile for at least 48 hours, completing a total of 14 days. 1

Follow-Up Recommendations

Monitor for symptom resolution - Persistent symptoms after 48-72 hours warrant culture review and therapy adjustment 2
Consider follow-up urine culture in complicated cases - Particularly if symptoms persist or recur 2
Address identified underlying abnormalities - Surgical correction may be necessary to prevent recurrence 1, 5

What is the best treatment approach for a male patient with a urinary tract infection (UTI), considering factors such as age, medical history, and presence of underlying conditions like diabetes or a weakened immune system?

Help us tailor your experience